Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: huntington disease

January 15, 2024 CD as API / Drug delivery / Pharma applications

Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans

The elevated occurrence of debilitating neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), Alzheimer’s disease (AD), Parkinson’s

Continue reading

August 30, 2023 CD derivatives / Drug delivery / Pharma applications

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin

Huntington’s disease (HD) is a progressive inherited neurodegenerative disease caused by a CAG repeat expansion in the huntingtin gene, which

Continue reading

February 16, 2023 Drug delivery / Pharma applications

Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach

Neurodegeneration is characterized by progressive, disabling, and incurable neurological disorders with the massive loss of specific neurons. As one of

Continue reading

February 4, 2021 CD as API / Drug delivery / Events

Press Release – Development of Autophagy Inducing Cyclodextrin Derivatives for Aging-associated Diseases

CycloLab Cyclodextrin R&D Ltd. proudly announces winning of a national grant about the development of cyclodextrin-dervatives for autophagy-associated neurodegenerative diseases.

Continue reading

Recent Posts

  • Self-assembly of Cationic Permethylated Cyclodextrins
  • Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery
  • Special issue: “Synthesis, Analysis and Applications of Cyclodextrins and Their Derivatives”
  • Multiscale mechanistic analysis of reversible cross-linking polymers based on host–guest interactions
  • Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (341)
  • CD derivatives (402)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (781)
  • E-ducation (63)
  • Environmental (131)
  • Events (232)
  • Food (217)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (393)
  • Other industrial use (104)
  • Pharma applications (1,168)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery
  • Self-assembly of Cationic Permethylated Cyclodextrins
  • Special issue: “Synthesis, Analysis and Applications of Cyclodextrins and Their Derivatives”
  • Lanosterol eye drops for cataract treatment
  • Methyl alpha-CD for lipid exchange in cell membrane
  • Chemical modification of β-cyclodextrin towards hydrogel formation
  • Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
  • Cyclodextrins to preserve and analyze whisky flavor
  • 45 years of paracetamol (acetaminophen)–beta-cyclodextrin complex history - now used in versatile pharmaceuticals
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers
 

Loading Comments...